Dr. Hendrik-Tobias Arkenau
Oncology
Sarah Cannon Cancer Institute
Consultant Oncologist
Dr. Hendrik-Tobias Arkenau is the founding Medical Director of Sarah Cannon Research Institute UK and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the Hospital Corporation of America International Cancer Service Line. He received his medical degree in 2000 at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. Since SCRI inauguration in 2010, Dr Arkenau has built up a trial portfolio of >150 early clinical trials. As Chief- and Principal Investigator he is actively involved in protocol development, toxicity review, pharmacokinetic analysis, biomarker and strategic development of new anti-cancer drugs, including immunotherapies. He has presented multiple talks on the latest research in Oncology and has been Invited Speaker at several national/international meetings. Dr Arkenau has published articles in international peer-reviewed journals and serves as ‘Contributing Associate Editor-in-Chief’ of the World Journal of Gastroenterology and ‘Associate Editor’ of World Journal of Cancer Research.
  • Honorary Consultant post with UCL Hospitals
  • Fellow of the Royal College of Physicians
  • Member of The German Cancer Society, ASCO, AACR and ESMO
Expertise
  • protocol development
  • toxicity review, pharmacokinetic analysis, biomarker
  • strategic development of new anti-cancer drugs
  • immunotherapies

Make an Appointment

X Icon
INQUIRE MORE
CONTACT US
+86
400 9999 260
For any comment or suggestion
PLEASE LEAVE YOUR INFORMATION

Circle Harmony Xintai Clinic
Bldg. 11, InterContinental Shanghai Ruijin, Huangpu, Shanghai
关  闭